Home Nucleus Healthcare U.S. Laboratory-Developed Tests (LDTs) Market to 2032

U.S. Laboratory-Developed Tests (LDTs) Market to 2032

Overview

The U.S. Laboratory-Developed Tests (LDTs) Market is expected to reach a 17,390.92 USD Billion by 2032 and is projected to grow at a CAGR of 19.31% from 2025 to 2032.

Revenue, 2024 (USD Billion)
6,481.24
Forecast, 2032 (USD Billion)
17,390.92
CAGR, 2024 - 2032
19.31%
Report Coverage
U.S.

U.S. Laboratory-Developed Tests (LDTs) Market 2018-2032 USD Billion

U.S. Laboratory-Developed Tests (LDTs) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 6,481.24 USD Billion
  • Projected Market Size (2032): 17,390.92 USD Billion
  • CAGR (2025-2032): 19.31%

Key Findings of U.S. Laboratory-Developed Tests (LDTs) Market

  • The U.S. Laboratory-Developed Tests (LDTs) Market was valued at 6,481.24 USD Billion in 2024.
  • The U.S. Laboratory-Developed Tests (LDTs) Market is likely to grow at a CAGR of 19.31% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Male in Gender Segment accounted for the largest share of the market with a revenue of 4,768.13 USD Billion
  • The fastest growing segment Infections in Therapeutic Area Segment grew Fastest with a CAGR of 21.63% during the forecast period from 2024 to 2032.

U.S. Laboratory-Developed Tests (LDTs) Market Scope

U.S. Laboratory-Developed Tests (LDTs) Market Segmentation & Scope
Sample Type
  • Cerebrospinal Fluid (CSF)
  • Tissue
  • Urine
  • Blood
  • Others
Therapeutic Area
  • Gynecology
  • Urology
  • Autoimmune Disease
  • Others
  • Oncology/Cancer
  • Genetic Disorders
  • Infections
Test Type
  • Other Test
  • Microbiology
  • Molecular Diagnostics
  • Haematology
  • Critical Care
  • Clinical Chemistry and Immunology
Product Type
  • Accessories
  • Analyzers and Instruments
  • Consumables
Gender
  • Female
  • Male
Age Group
  • Pediatric
  • Adult
  • Geriatrics
End Users
  • Specialty Diagnostic Centers
  • Clinical Research Organizations
  • Academic Institutes
  • Diagnostic Chains
  • Stand-Alone Labs
  • Hospital-Based Labs
  • Others
Distribution Channel
  • Others
  • Third Party Distributors
  • Retail Sales
  • Direct Tender

U.S. Laboratory-Developed Tests (LDTs) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 6,481.24 USD Billion
Market Value in 2032 17,390.92 USD Billion
CAGR (2025-2032) 19.31%
Historic Data 2016-2023
Market Segments Covered Sample Type,Therapeutic Area,Test Type,Product Type,Gender,Age Group,End Users,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 6,481.24 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 6,481.24 USD Billion in 2024.

Segments and Scope

  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Sample Type
    • Blood is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 330.29 USD Billion in the year 2024.
    • Blood is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 20.27 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Therapeutic Area
    • Infections is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 2,020.12 USD Billion in the year 2024.
    • Infections is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 21.63 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Test Type
    • Clinical Chemistry and Immunology is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 2,120.48 USD Billion in the year 2024.
    • Clinical Chemistry and Immunology is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 20.00 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Product Type
    • Consumables is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 3,436.25 USD Billion in the year 2024.
    • Consumables is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 19.85 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Gender
    • Male is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 4,768.13 USD Billion in the year 2024.
    • Male is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 19.38 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Age Group
    • Geriatrics is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 3,397.24 USD Billion in the year 2024.
    • Geriatrics is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 19.77 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By End Users
    • Hospital-Based Labs is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 305.34 USD Billion in the year 2024.
    • Hospital-Based Labs is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 19.88 % in forecast period 2025-2032.
  • U.S. Laboratory-Developed Tests (LDTs) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a revenue of 2,538.34 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Laboratory-Developed Tests (LDTs) Market to 2032 with a Growth rate of 20.26 % in forecast period 2025-2032.

U.S. Laboratory-Developed Tests (LDTs) Market Company Share Analysis

 
Company Name Company Share Analysis
Sysmex
Quest Diagnostics Incorporated
BIOMÉRIEUX
Biomerics
Bio-Rad Laboratories, Inc.
U.S. Laboratory-Developed Tests (LDTs) Market Company Share Analysis

U.S. Laboratory-Developed Tests (LDTs) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Laboratory-Developed Tests (LDTs) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Laboratory-Developed Tests (LDTs) Market Company Profiling

U.S. Laboratory-Developed Tests (LDTs) Market Company Profiling

Industry Related Reports

Asia-Pacific Discharge Inks Market for Textile Industry Market
Europe Discharge Inks Market for Textile Industry Market
North America Discharge Inks Market for Textile Industry Market
Middle East & Africa Discharge Inks Market for Textile Industry Market
South America Discharge Inks Market for Textile Industry Market
United Arab Emirates Discharge Inks Market for Textile Industry Market
Argentina Discharge Inks Market for Textile Industry Market
Australia Discharge Inks Market for Textile Industry Market
Belgium Discharge Inks Market for Textile Industry Market
Brazil Discharge Inks Market for Textile Industry Market
Frequently Asked Questions
The U.S. Laboratory-Developed Tests (LDTs) Market is segmented based on Segmentation Sample Type,Therapeutic Area,Test Type,Product Type,Gender,Age Group,End Users,Distribution Channel.
U.S. Laboratory-Developed Tests (LDTs) Market was valued at USD 6,481.24(Revenue in USD Billion) in 2021.
U.S. Laboratory-Developed Tests (LDTs) Market is projected to grow at a CAGR of 19.31% during the forecast period of 2024 to 2032.
The Male segment is expected to dominate the U.S. Laboratory-Developed Tests (LDTs) Market, holding a largest market share of 4,768.13 USD Billion in 2024

Coming Soon....

U.S. Laboratory-Developed Tests (LDTs) Market Scope

U.S. Laboratory-Developed Tests (LDTs) Market Segmentation & Scope
Sample Type
  • Cerebrospinal Fluid (CSF)
  • Tissue
  • Urine
  • Blood
  • Others
Therapeutic Area
  • Gynecology
  • Urology
  • Autoimmune Disease
  • Others
  • Oncology/Cancer
  • Genetic Disorders
  • Infections
Test Type
  • Other Test
  • Microbiology
  • Molecular Diagnostics
  • Haematology
  • Critical Care
  • Clinical Chemistry and Immunology
Product Type
  • Accessories
  • Analyzers and Instruments
  • Consumables
Gender
  • Female
  • Male
Age Group
  • Pediatric
  • Adult
  • Geriatrics
End Users
  • Specialty Diagnostic Centers
  • Clinical Research Organizations
  • Academic Institutes
  • Diagnostic Chains
  • Stand-Alone Labs
  • Hospital-Based Labs
  • Others
Distribution Channel
  • Others
  • Third Party Distributors
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The U.S. Laboratory-Developed Tests (LDTs) Market is segmented based on Segmentation Sample Type,Therapeutic Area,Test Type,Product Type,Gender,Age Group,End Users,Distribution Channel.
U.S. Laboratory-Developed Tests (LDTs) Market was valued at USD 6,481.24(Revenue in USD Billion) in 2021.
U.S. Laboratory-Developed Tests (LDTs) Market is projected to grow at a CAGR of 19.31% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Laboratory-Developed Tests (LDTs) Market for final year is USD 17,390.92 (USD Billion).

U.S. Laboratory-Developed Tests (LDTs) Market Company Profiling

U.S. Laboratory-Developed Tests (LDTs) Market Company Profiling
Frequently Asked Questions
The U.S. Laboratory-Developed Tests (LDTs) Market is segmented based on Segmentation Sample Type,Therapeutic Area,Test Type,Product Type,Gender,Age Group,End Users,Distribution Channel.
U.S. Laboratory-Developed Tests (LDTs) Market was valued at USD 6,481.24(Revenue in USD Billion) in 2021.
U.S. Laboratory-Developed Tests (LDTs) Market is projected to grow at a CAGR of 19.31% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Laboratory-Developed Tests (LDTs) Market for final year is USD 17,390.92 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.